{
    "title": "113_hr4287",
    "content": "The \"Independent Innovator and Repurposing Act\" may extend the patent term for using biological products. The \"Independent Innovator and Repurposing Act\" allows for a 5-year extension of a patent for using biological products, if certain conditions are met. To obtain an extension of a patent for a biological product, the owner must submit an application to the Director with specific details, and the patent must not have expired or been previously extended. To extend a patent for a biological product, the owner or agent must submit an application to the Director with details including the biological product's identity, the patent's identity, and proof that the patent was issued to an independent innovator. To extend a patent for a biological product, the owner must demonstrate that the patent was issued to an independent innovator or a qualified small business in which the innovator has an ownership interest. Additionally, an application for commercial marketing of the product must be filed. To extend a patent for a biological product, the owner must demonstrate that the patent was issued to an independent innovator or a qualified small business in which the innovator has an ownership interest. Additionally, an application for commercial marketing of the product must be filed, and a period of at least 10 years must have elapsed between the original submission of an application for investigating the method of use and FDA approval. To extend a patent for a biological product, the owner must demonstrate that the patent was issued to an independent innovator or a qualified small business. An application for commercial marketing of the product must be filed, and at least 10 years must have elapsed between the original submission of an application for investigating the method of use and FDA approval. The owner of record of the patent or their agent must provide a brief description of activities undertaken with respect to the biological product during this period. To determine patent extension eligibility for a biological product, the Director relies on the application's representations. If the requirements are met, the Director will issue the extension. The Director will issue a certificate of extension for 5 years if a patent is eligible and requirements are met. An interim extension may be granted if the patent term would expire before the certificate is issued or denied. The Director may grant an interim extension of up to one year for a patent if the term would expire before a certificate of extension is issued or denied. The term \"biological product\" is defined in this section. The Director may grant an interim extension of up to one year for a patent if the term would expire before a certificate of extension is issued or denied. Definitions in this section include \"biological product\" and \"Director.\" An \"independent innovator\" is defined as a person or entity obtaining a method of use patent. An \"independent innovator\" is defined as a person or entity obtaining a method of use patent for a biological product, not affiliated with the holder of a marketing application approved under section 351(a) of the Public Health Service Act. The term \"affiliated\" in the context of a marketing application approved under section 351(a) of the Public Health Service Act refers to any relationship of employment, control, or common ownership, whether direct or indirect. A \"qualified small business\" is defined as any entity with fewer than 500 employees. The term \"qualified small business\" refers to an entity with fewer than 500 employees, not affiliated with the holder of a marketing application approved under section 351(a) of the Public Health Service Act. This section will take effect on the enactment date of the Act and applies to any unexpired patent issued before or after that date."
}